CD86 and tick-borne encephalitis: To investigate the activation status of DC after encountering TBEV, we stimulated PBMCs from VBT and unvaccinated TBE patients in vitro with TBEV (MOI 2) for 24 and 48 hours and measured the expression of the activation and maturation markers HLA-DR and CD86 on specific DC subpopulations.